Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Most linked-to pages

From GxPlex

Jump to: navigation, search

Showing below up to 50 results in range #701 to #750.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 7 (6 links)
  2. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 77 (6 links)
  3. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 78 (6 links)
  4. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 8 (6 links)
  5. Reference:EU Regulation (EU) No 520/2012 - performance of pharmacovigilance activities 20-Jun-12 Annex III 1. (6 links)
  6. Reference:EU Regulation (EU) No 520/2012 - performance of pharmacovigilance activities 20-Jun-12 Annex III 2. ; 3. (6 links)
  7. Reference:FRA AEC DOC012 v03 Avis aux promoteurs d’investigations cliniques de DM (RIPH1) – Partie II 16-May-2025 3. (6 links)
  8. Reference:FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 Article R1121-3-1 (6 links)
  9. Reference:FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 Article R1123-20 (6 links)
  10. Reference:FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 R1123-46 (6 links)
  11. Reference:FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 R1123-53 (6 links)
  12. Reference:FRA SI RIPH 2G - Website 16-May-2025 - (6 links)
  13. Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 17 (6 links)
  14. Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (a) (6 links)
  15. Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (c) (6 links)
  16. Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (l) (6 links)
  17. Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (m) (6 links)
  18. Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (o) (6 links)
  19. Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex VIII 1. ; 2. ; 2.2 (6 links)
  20. Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex X 2.3.7 (6 links)
  21. Reference:GBR Directive 93/42/EEC 11-Oct-2007 Article 15 6. - 7.-002 (6 links)
  22. Reference:GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 Appendix I (6 links)
  23. Reference:GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 D What needs to be reported (6 links)
  24. Reference:GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 D When should the notification be made (6 links)
  25. Reference:GBR Guidance - Good clinical practice for clinical trials 16-Oct-2015 - (6 links)
  26. Reference:GBR MEDDEV 2.7/3 revision 3 May-2015 8 (6 links)
  27. Reference:GBR NHS: Records Management Code of Practice 07-Aug-2023 - (6 links)
  28. Reference:GBR The Human Medicines Regulations 2012 01-Jan-2025 Article 51B (6 links)
  29. Reference:GBR The Medical Devices Regulations 2002 11-Feb-2021 Article 16 (1) - (3) (6 links)
  30. Reference:GBR The Medical Devices Regulations 2002 11-Feb-2021 Article 18 (6 links)
  31. Reference:GBR The Medical Devices Regulations 2002 11-Feb-2021 Article 2 in vitro diagnostic medical device (6 links)
  32. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 11 (6 links)
  33. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 11 - 12 (6 links)
  34. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (5) (k)-(l) (6 links)
  35. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (7) - (10) (6 links)
  36. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 17 (6 links)
  37. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 18 (6 links)
  38. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 19 - 20 (6 links)
  39. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 25 (6 links)
  40. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 (1) (6 links)
  41. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 adverse event adverse reaction (6 links)
  42. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 clinical trial (6 links)
  43. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 investigator (6 links)
  44. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 non-interventional trial (6 links)
  45. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 unexpected adverse reaction (6 links)
  46. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 32 (6 links)
  47. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 33 (6 links)
  48. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 34 (6 links)
  49. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 35 (6 links)
  50. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 3 (6) - (11) (6 links)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://gxplex.org/index.php?title=Special:MostLinkedPages"